---
title: "InSilico Medicine 預計 2025 年虧損將進一步擴大；股價上漲 4%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/278327366.md"
description: "InSilico Medicine 預計 2025 年虧損將擴大；股價上漲 4%"
datetime: "2026-03-09T04:45:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278327366.md)
  - [en](https://longbridge.com/en/news/278327366.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278327366.md)
---

# InSilico Medicine 預計 2025 年虧損將進一步擴大；股價上漲 4%

InSilico Medicine Expects 2025 Losses to Widen; Shares Gain 4%

### 相關股票

- [XLV.US](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [IHE.US](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [IBB.US](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [ARKG.US](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [PRME.US](https://longbridge.com/zh-HK/quote/PRME.US.md)
- [FBT.US](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [MNMD.US](https://longbridge.com/zh-HK/quote/MNMD.US.md)
- [BIB.US](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [IXJ.US](https://longbridge.com/zh-HK/quote/IXJ.US.md)
- [XBI.US](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [INRX.US](https://longbridge.com/zh-HK/quote/INRX.US.md)
- [VHT.US](https://longbridge.com/zh-HK/quote/VHT.US.md)

## 相關資訊與研究

- [雙雙入選 2026 SGO 口頭報告：蘆康沙妥珠單抗 (sac-TMT) 兩項婦科腫瘤研究成果發佈](https://longbridge.com/zh-HK/news/282607157.md)
- [鉅亨速報 - Factset 最新調查：阿里拉姆製藥 (ALNY-US) EPS 預估下修至 6.57 元，預估目標價為 447.00 元](https://longbridge.com/zh-HK/news/282708759.md)
- [藥廠 AI 合作潮！諾和諾德攜手 OpenAI 股價走揚](https://longbridge.com/zh-HK/news/282755292.md)
- [諾和諾德夥 OpenAI 研發藥物 AI 分析數據 識別具潛力候選藥](https://longbridge.com/zh-HK/news/282661383.md)
- [諾和諾德與 OpenAI 攜手，以 AI 加速開發肥胖與代謝藥物](https://longbridge.com/zh-HK/news/282666368.md)